A major trial led by the University of Bristol and North Bristol NHS Trust is exploring a panel of blood tests to detect dementia faster and more accurately across diverse UK populations.
Cambridge Vision Technology utilises AI-based technology to detect Alzheimer’s disease early on by using ocular biomarkers. They emphasise the importance of early detection of dementia to improve clinical outcomes for disease therapies and to maximise the economic and societal impact of this innovative new technology.
Researchers at the Perelman School of Medicine at the University of Pennsylvania have reported improvements in vision among patients with a rare inherited condition, following gene therapy.
The latest European Society of Cardiology (ESC) guidelines on chronic coronary syndromes (CCS) mark a significant shift in how cardiologists approach and treat heart conditions.
Dr Rayaz A Malik, Professor of Medicine at Weill Cornell Medicine-Qatar, discusses the challenges and impact of misdiagnosis and late diagnosis in type 1 diabetes.
Quantified Imaging, originating from the University of Nottingham, specialises in advanced MRI techniques to improve dementia care, diagnosis, monitoring, and treatment.
Symptoms of Monkeypox can take 5 to 21 days to appear, so it's important to be aware of the signs during this time and remain in isolation as it is contagious.
A groundbreaking new tool, The Glaucoma Field Defect Classifier (GFDC), developed by eye specialists at Addenbrooke’s Hospital, could transform glaucoma diagnosis and help change the way its managed worldwide.
Open Access Government discusses the prevalence of neglected tropical diseases, including barriers to awareness and the need to scale up effective interventions.
Despite affecting a significant portion of the population, the impact of rheumatic and musculoskeletal diseases (RMDs) is often underestimated, with many people living with RMDs, and their families, in need of greater care and support. Lynne Woolley at Versus Arthritis spoke to Lorna Rothery about the physical and psychological challenges of RMDs and what can be done.
Sabih Chaudhry, CEO of Afon Technology Ltd, describes the company’s innovative Glucowear™ — the world’s first non-invasive, real-time, and continuous blood glucose sensor.
